News

Dan Myers Named Director of Virginia SBDC, Innovation Commercialization Assistance Program to Accelerate Tech-Driven Growth in the Commonwealth

The Virginia Small Business Development Center (SBDC) is pleased to announce that Dan Myers has been named the new Director for the Virginia SBDC – Innovation Commercialization Assistance Program (ICAP).

Dan, a seasoned innovation strategist, will lead the Virginia SBDC – ICAP program that is designed to help Virginia small businesses turn ideas into commercial success. In his new role, Dan will lead the program efforts to support Virginia based innovators and entrepreneurs in bringing high potential technologies and innovations to market, strengthening the state’s innovation ecosystem and advancing economic growth.

With years of experience in innovation management, technology transfer, and startup acceleration, Dan brings a proven track record of guiding early-stage technologies from concept to commercialization. Prior to this new role, he served as a Virginia SBDC – ICAP mentor. Dan will now oversee the program team, develop strategic partnerships, and expand outreach to innovation communities across Virginia.

“Virginia is at a critical inflection point in building a vibrant innovation economy,” said Jody Keenan, State Director of the Virginia SBDC Network. “With Dan on board, we’re committed to move ideas off the bench and into real businesses that create jobs and add value here in the Commonwealth.”

“We live in a moment where Virginia’s entrepreneurial talent, research institutions, and industry partners are aligning,” said Dan Myers. “My priority is to remove friction from the path of innovation so that bright ideas become meaningfully impactful businesses and challenges in the world find built solutions. That means working hand in hand with entrepreneurs, universities, and ecosystem partners in order to see early-stage tech startups, biotech & bioscience companies, and other scalable businesses thrive in Virginia.”

Recent News

07/15/2026

Focused Ultrasound Foundation Chairman Receives Lifetime Impact Award

Neal F. Kassell, MD, founder and chairman of the Focused Ultrasound Foundation, received the inaugural Lifetime Impact Award at the 2026 annual meeting of the International Society for Therapeutic Ultrasound (ISTU) in Norway in June. The award honors individuals whose work has fundamentally shaped the development, adoption, and global impact of focused ultrasound. “Dr. Kassell’s

07/14/2026

ARPA-H awards up to $160 million to advance personalized curative medicines for rare genetic diseases

The Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department of Health and Human Services, today announced the teams for the Treating Hereditary Rare Diseases with In Vivo Precision Genetic Medicines (THRIVE) program — a critical investment toward bringing new treatments to patients faster and cure rare genetic pediatric diseases. THRIVE

07/09/2026

Quoin Pharmaceuticals Receives FDA IND Clearance to Initiate Phase 2 Study of QRX003 in Peeling Skin Syndrome

Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, announced that the U.S. Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application for QRX003 for the treatment of Peeling Skin Syndrome (PSS), enabling initiation of its planned Phase 2 clinical study. Quoin